AstraZeneca Cherry-Picked Data, Misrepresented Vaccine’s Efficacy, Independent Medical Board Alleges

Posted on AllSides March 23rd, 2021
From The Right

An independent panel of medical experts overseeing AstraZeneca’s coronavirus vaccine trial accused the pharmaceutical company of cherry-picking favorable data, The New York Times reported.

The Data and Safety Monitoring Board (DSMB) alleged that AstraZeneca misrepresented the results of its coronavirus vaccine trial when it announced Monday morning that the vaccine had 79% efficacy at preventing symptomatic coronavirus, according to the NYT. The panel wrote a sharply-worded letter to the British pharmaceutical company and U.S. health officials hours after the results were released, triggering the National Institute of Allergy and Infectious...

Read full story
Some content from this outlet may be limited or behind a paywall.
https://dailycaller.com/2021/03/23/astrazeneca-coronavirus-vaccine-national-institutes-of-health/

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right